Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology

Front cover

Publication Ethics and Malpractice Statement

Publication Ethics and Publication Malpractice Statement compiled in accordance with Committee on Publication Ethics (COPE’s) Guidelines and Scopus Publication Ethics and Malpractice Statement Requirements.

1. Introduction of the Journal and Its Website

Journal’s Official Title

Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology

Acronym

JDTOMP

Aimes & Scope

Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology is a surgical fully open access and online-only peer-reviewed journal focused on publishing the articles dedicated to oral and maxillofacial surgery. Among published topics are: microvascular and jaws reconstructive surgery, dental implants, salivary gland tumors/diseases, the temporomandibular joint lesions, orthognathic surgery, implementation of ultrasound into the practice of oral and maxillofacial surgeons.

All articles will be peer reviewed for acceptance by editors for publication in the journal. Authors will be notified of this desicion and at the same time requested to pay an Article Publishing Charge (APC). Following payment of this charge (synonym: fee), articles will be made universally available and no further charge through dtjournal.org.

INTERNATIONAL STANDARD SERIAL NUMBER (ISSN)

Online (synonym: electronic) ISSN: 2522-1965 (link).

From 2017 to 2021 (before the transition to digital-only pulication [Fig 1]) the journal also used Print ISSN: 2519-2086. ISSNs were obtained at ISSN International Center. ISSN International Center`s address: 45 rue de Turbigo, 75003 Paris, France.

All the details about the transition to online-only pulication are in the article.

FIGURE 1. Print issue of the journal before the transition to digital-only pulication in January 2022 (read the article).

FREQUENCY

12 online issues (with a print option) a year (from January 2020).

PUBLICATION HISTORY

2017: 4 issues a year

2018: 4 issues a year

2019: 10 issues a year

2020 to present: 12 issues a year (i.e., monthy publication)

STANDARD ABBREVIATION: ISO 4

J. Diagn. Treat. Oral Maxillofac. Pathol.

Standard abbreviation usually used in references, ie, when authors are citing an article from a particular journal. In this case, the dots may not be used or put one dot at the end of the last title`s word which is abbreviated.

Example: Hanna TC, Kraus DH. State of the art simultaneous bilateral segmental mandibular reconstruction using a single fibula transplant: discussion of the surgical steps. J Diagn Treat Oral Maxillofac Pathol 2019;3(3):76−103. https://doi.org/10.23999/j.dtomp.2019.3.2

2. Name of Journal

The journal`s name (Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology) is unique and indicates how important in modern life of oral and maxillofacial surgeons both the diagnostics and treatment. Ultrasonography, computed tomography, magnetic resonance and many others imaging techniques continue to develop, more surgeons receive additional degrees in those fields. Productive collaboration of Dr. Fesenko (Managing Editor) and Dr. Ahuja (Section Editor) in the field of oral and maxillofacial and head neck ultrasound helped to attract more articles with ultrasound imaging modality than other journals focused on oral and maxillofacial surgery.

3. Peer Review Process

After submission to Editorial Office/Managing Editor the peer review process consist of 5 steps:

Peer reviewers selected by clinical expertise.
Reviewers' comments received by Editor-in-Chief/Managing Editor.
Initial decision sent to authors.
Revised manuscript reviewed by Editor-in-Chief/Managing Editor to ensure that reviewer's suggestions have been addressed. On occasion, the original reviewers also review the revised manuscript.
Final decision sent to author and at the same time requested to pay an article processing charge (Table 1). Following payment of this fee, the article will be made universally available at no further charge through dtjournal.org.

The journal employs “double blind” rigorous reviewing.

Editorial Office e-mail: editorial.office@dtjournal.org

TABLE 1. Article Publishing Costs (Synonym: Article Processing Charge).

Tier	Article Type	Article Publishing Charge
Tier 1	Case Report Case Series Original Article Review Article Technique Viewpoint Discussion Pictorial Essay	$500 USD (excluding tax)
Tier 2	Images Letter to the Editor	$250 USD (excluding tax)

Peer-Review Time

The mean time to first decision after the manuscript submission is 19 days.

4. Ownership and Management: Co-Founders of the Journal

Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology is published for the Ukrainian Association for Maxillofacial and Oral Surgeons (UAMOS) by three co-founders:

Shupyk National Healthcare University of Ukraine (formerly known as Shupyk National Medical Academy of Postgraduate Education), Kyiv, Ukraine.
Private Higher Educational Establishment “Kyiv Medical University,” Kyiv, Ukraine.
OMF Publishing, Limited Liability Company, Kyiv, Ukraine.

Shupyk National Healthcare University of Ukraine and Kyiv Medical University provide scientific support for the publication of the journal and OMF Publishing provides publishing process, marketing, advertising, etc.

5. Governing Body

Editorial Board (EB) (link) shows significant geographic diversity representing 28 opinion leaders from 13 countries: Brazil, Canada, Colombia, Greece, Hong Kong (SAR, China), India, Israel, Italy, Slovak Republic, Spain, Ukraine, the United Arab Emirates, and the United States of America (Fig 3).

FIGURE 3. Professor Tymofieiev, Chief Editor (left) and Professor Fernandes, Deputy Chief Editor (right) at 1st International Scientific Congress of the Azerbaijan Society of Oral and Maxillofacial Surgeons. 14 March, 2019; Baku, Azerbaijan.

The majority of the EB members (80.96%, i.e. 17 members) have a discernible publication history in Scopus, Web of Science, and journals with a high impact factor.
The publication records of all EB members (Fig 4) are consistent with the stated scope and published content of the journal.
The journal have several full-time professional editors.
Gender distribution of the editors: 10.34% women, 89.65% men, 0% non-binary/other, and 0% prefer not to disclose.
In January 2022 was launched a unique position of Resident Ambassador (read the editorial) and Dr. Le (link) from University of Alabama at Birmingham (USA) became the Founding Ambassador.

FIGURE 4. Associate Professor Salman, Section Editor with journal`s award plaque. 14 March, 2018; Jacksonville, FL, USA.

6. Editorial Team/Contact Information

The full names and affiliations of the journal’s editors are at the Editorial Board page.

Editorial Office address: 13-A Simferopolska Street, office 121, Kyiv 02096, Ukraine. Map

Editorial Office e-mail: editorial.office@dtjournal.org.

7. Copyright and Licensing

User Rights

All papers published by the journal will be free to every person to download, read, copy, and distrubute. Permission for reuse will be defiened by your choice of one of the next user licenses:

Creative Commons Attribution (CC BY): let others copy and distribute the article, to extracts, abstracts, and other revised versions, adatpations or derivative works of or from an article (such as translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and not modify the article in such a way as to damage the author`s honor or reputation.
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): For non-commercial purposes, lets others copy and distribute the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not allert or modify the article.

Author Rights

For open access publishing this journal uses an exclusive licensing agreement. Authors will retain copyright alongside scholarly usage rights and OMF Publishing will be granted publishing and distribution rights.

Embargo Policy

Any content submitted to the journal must not be discussed with the media until the paper has published (online or in print, whichever occurs first). The journal reserves the right to halt the consideration or publication of a paper if this policy is broken. If your paper is newsworthy, you may recommend a press release to the Managing Editor or Editorial Office. You or your institution may also arrange for your own publicity; however you must strictly adhere to the Journal’s embargo policy and are advised to notify the Editorial Office if you or your institution chooses to conduct a press release.

8. Author Fees

TABLE 2. Article Publishing Fees

Tier	Article Type	Article Publishing Fees
Tier 1	Case Report Case Series Original Article Review Article Technique Viewpoint Discussion Pictorial Essay	$500 USD (excluding tax)
Tier 2	Images Letter to the Editor	$250 USD (excluding tax)

9. Process for Identification of and Dealing with Allegations of Research Misconduct

Plagiarism is when an author passes of the work of someone else as his or her own. This can also include self-plagiarism, which happens when an author reuses portions of his or her previously published work without the proper references. Manuscripts containing plagiarized content will not be considered for publication in Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology.

All authors need to take responsibility for their manuscripts. If your name is on a manuscript, make sure all of the material in the paper either is original or is properly cited and has proper permission to be reproduced. If you have a question about the originality of any part of a manuscript, verify it with your coauthors. Senior authors should pay special attention to what the junior authors are doing and where they are sending their manuscripts.

If you realize you have made an error of dual publication or plagiarism inadvertently, proactively contact the editorial office. It is much better to come forward of your own volition than to have an accusation made against you.

If the journal learns of a case of plagiarism after publication, the journal will conduct an investigation. If plagiarism is found, the author, the author’s institution and funding agencies, and the original publication will be notified. A statement noting the plagiarism, providing a reference to the plagiarized material, and linking to the original to the original paper may follow. Depending on the extent of the plagiarism, the paper may also be formally retracted.

The use of “Cross Check” program is strategically helping us to discover instances of misconduct at the earliest stages of manuscript submission.

More details about the plagiarism and dual publications are in the article of Rohrich et al (2009).

10. Publication Ethics

10.1. Authorship

According to the International Committee on Medical Journal Editors (ICMJE), an author is defined as one who has made substantive intellectual contribution to the development of a manuscript. The ICMJE guidelines state that “authorship credit should be based on:

1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; and

2) drafting the article or revising it critically for important intellectual content; and

3) final approval of the version to be published; and

4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Authors should meet conditions 1, 2, 3, and 4. If more than 10 authors are listed for any given manuscript, the overage will be relocated to the “Acknowledgment” section of the manuscript. Special exceptions to this rule can be sought via special request. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the Editor from the authors concerned. This letter must be signed by all authors on the paper.

Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology will consider name change requests for reasons including, but not limited to, gender identity, marriage, divorce, and religious conversion.

Ghostwriting is not permitted by the journal. Manuscripts are received with the understanding that they have not been written by unacknowledged freelance writers. Guest authorship and “gift” authorship are also prohibited.

Professional writers and medical writers who contribute substantially to the writing or editing of a manuscript should be acknowledged with their permission or credited in the author list. The financial nature of their contract must be disclosed.

Any clinical manuscripts (the subjects of which are humans, not experimental papers, or manuscripts that have clinical implications or applications) have as its first and corresponding author a practicing physician(s). Coauthors from industry can certainly be included on a paper, but the corresponding author who takes ultimate senior responsibility on the paper must be a practicing clinical physician.

Senior/Corresponding authors must sign a form indicating that the author group listed is solely responsible for the generation of content of the article, and that the article was not ghostwritten and did not have any other unlisted authors. Authors accept responsibility and accountability for the content of the article; the authors- not an industry sponsor- have the final say in what goes into a manuscript. Severe penalties may be incurred if it is later discovered that authorship is not as it was attested to be.

By publishing in Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology, The Author(s) retain copyright of their content and grant the Ukrainian Association for Maxillofacial and Oral Surgeons and its Affiliates the exclusive, worldwide, royalty free, perpetual (for the duration of the applicable copyright) right and license to use the Work for all commercial purposes, including, but not limited to, publishing, reproducing, marketing, distributing (themselves and through distributors), sublicensing, and selling copies of the Work throughout the world for the Term. If the Author is a Ukraine government employee, such license grant shall be limited to the extent the Author is able to grant such license.

The Work will be published by the Ukrainian Association for Maxillofacial and Oral Surgeons in Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology and made freely available to users under the terms of the Attribution-NonCommercial-NoDerivs 3.0 Creative Commons License, as currently displayed at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode (the “CCL”). Authors must acknowledge and agree that OMF Publishing is the exclusive “Licensor”, as defined in the CCL, of the Work and that OMF Publishing may make the Work freely available to all users under the terms of the CCL.

Academic Degrees for Authors

Please limit the total number of academic degrees to a maximum of three (3).

Corresponding Author Contact Information Page

On the second page, the complete name and address of the corresponding author, or the author who is responsible for handling reprints, must appear. This information must include an e-mail address.

Financial Disclosure and Products Page

On the third page of the manuscript, all sources of funds supporting the work and a statement of financial interest, if any, must be included for each author, along with a list of all products, devices, drugs, etc., used in the manuscript. All manuscripts must have all of this information.

Each author must disclose at the time of submission any commercial associations or financial disclosures that might pose or create a conflict of interest with information presented in any submitted manuscript. Such associations include consultancies, stock ownership, or other equity interests, patent licensing arrangements, and payments for conducting or publicizing a study described in the manuscript. Authors must disclose any funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s). This information will be printed with the article.

Much of this policy is adapted from the article “Authorship and Medical Ghostwriting: Plastic and Reconstructive Surgery Policy” (Sullivan and Rohrich, 2011). Please review this article for more information, definitions and assistance. Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology will follow the same authorship and ghostwriting policies as the peer-reviewed publication Plastic and Reconstructive Surgery.

Author Contributions

Availability of contributor role information is a key part of oral and maxillofacial surgery study. In our journal`s policy we adhere to the author contributions principles highlighted in the work of Allen et al (2018) “How Can We Ensure Visibility and Diversity in Research Contributions? How the Contributor Role Taxonomy (CRediT) Is Helping the Shift from Authorship to Contributorship.” After specifying conflicts of interest the role of co-authors in writing of the article (concept and design of the study; material collection, material processing, statistical data processing, writing text, editing, etc.) should be designated.

10.2. How Our Journal Will Handle Complaints and Appeals

PRINCIPLES

We will abide by the following principles when investigating complaints and appeals:

Fairness: we will endeavour to treat all parties involved in a complaint fairly and to avoid bias either in process or outcome. We will avoid conflicts of interest.
Confidentiality: we will only disclose information necessary to resolve a complaint, and in accordance with The General Data Protection Regulations.
Clarity: we will seek to be clear in all our communication, taking into account the needs of those we are communicating with.
Speed: we will endeavour to resolve complaints as quickly as possible. It should be noted that some investigations are complex and take time to resolve equitably (for example, allowing reasonable time for multiple parties to respond).

PROCESS

OMF Publishing will acknowledge receipt of an email sent to office@omfpublishing.com within 5 business days. Our Manager will then lead the investigation following COPE Guidelines. The investigation will establish whether the correct procedures have been followed and assess whether the author’s concerns have been addressed fairly and without prejudice. OMF Publishing will review the paper’s peer review history and any correspondence between the author, editor and reviewers. OMF Publishing may also contact the parties involved to obtain further information where necessary and in accordance with The General Data Protection Regulations.

The author will be advised of the outcome in writing. We aim to resolve issues as swiftly as possible or within six weeks, though please note sometimes investigations can take several weeks or more depending on the nature of the concern or complaint, the availability of relevant data and information, whether multiple authors and papers are involved, and possible involvement of the author’s institution or other external parties.

In the interest of allowing due process to take place, and investigations to proceed without prejudice, we respectfully request that anyone raising a concern or complaint allow the process to conclude before publicly commenting on the case.

If the author wishes to pursue their complaint further, they may contact COPE directly. Information can be found on the COPE website: Facilitation and Integrity Subcommittee | COPE: Committee on Publication Ethics.

10.3. Journal policies on conflicts of interest/competing interests

All sources of funds supporting the work and a statement of financial interest, if any, must be included for each author of a manuscript, along with a list of all products, devices, drugs, etc. used in the manuscript. All manuscripts must have this information. Each author is required at the time of submission to disclose any commercial associations or financial disclosures that might pose or create a conflict of interest with information presented in any submitted manuscript. Such associations include any of the following: consultancies, stock ownership, or other equity interest, patent licensing arrangements, payments for conduction or publicizing a study described in the manuscript, royalty recipient, grant recipient, employee, board member and review panel member.

10.4. Journal policies on data sharing and reproducibility

At OMF Publishing we are committed to facilitating openness, transparency and reproducibility of research. We support and encourage research data to be shared, discoverable, citable, and recognized as an intellectual product of value.

All papers published by the journal will be free to every person to download, read, copy, and distrubute. Permission for reuse will be defiened by your choice of one of the next user licenses:

Creative Commons Attribution (CC BY): let others copy and distribute the article, to extracts, abstracts, and other revised versions, adatpations or derivative works of or from an article (such as translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and not modify the article in such a way as to damage the author`s honor or reputation.
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): For non-commercial purposes, lets others copy and distribute the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not allert or modify the article.

10.5. Journal’s Policy on Ethical Oversight

To ensure that the ethical standards of the journal are achieved, the editors of Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology provide ethical ethical oversight for the publication process.

Vulnerable Populations

Per the Committee on Publication Ethics (COPE), ethical oversight should include, but is not limited to, policies on consent to publication, publication on vulnerable populations, ethical conduct of research using animals, ethical conduct of research using human subjects, handling confidential data and ethical business/marketing practices.

For studies involving human or animal subjects, JSS requires that information about appropriate institutional review board approval be included with the submission or described within the article.

For research involving human subjects, authors should explain how informed consent was obtained from all participants. Informed consent should be obtained if there is any reasonable possibility that complete anonymity cannot be maintained. The privacy of human subjects should never be violated without prior informed consent. Identifying information should be excluded from the study data unless the information is essential for the study purposes and the subject (or their legal representative has given prior written informed consent. However, subject information should never be falsified or modified. When informed consent has been given by the subjects, it should be included in the article.

Publication Misconduct

JDTOMP is committed to detecting and preventing publication misconduct through its peer review and editing process. Peer reviews are instructed to perform routine checks for the following:

Plagiarism (i.e. using the ideas or work of others): Through routine use various online tools by peer reviewers. Reviewers should check for proper and adequate citations
Fabrication (i.e. making up data): Reviewers and editors should be cautious of “impressive” research results, and be aware of potential conflicts of interest. Raw data should be reviewed for signs of fabrication.
Falsification (i.e. manipulating research or modifying data): See recommendations for fabrication above. Reviewers should also check for unusual research methods or analysis methods.
Citation manipulation (see COPE guideline): Reviewers and editors will check for excessive self-citation, excessive citation of a single journal, and citations that do not support the research topic.
Peer review manipulation (see COPE statement): Peer reviewers are qualified per a screening process, and reviewer performance is monitored by JDTOMP editors.
Authorship misconduct: JDTOMP editors will implement the JDTOMP Authorship and Contributorship Policy

Reporting

Suspicion of violations of the ethical oversight policy should be made to Publisher (office@omfpublishing.com) via the Ethics Complaints and Appeals process.

10.6. Journal’s policy on intellectual property

JDTOMP requires authors to make their article open access under one of the Creative Commons Licenses in order to meet the terms of open access publication and ensure the widest possible dissemination.

10.7. Journal’s options for post-publication discussions and corrections

Every article published by a OMF Publishing journal, or a journal published by us on behalf of a scholarly society, either in the print issue or online, constitutes the Published Journal Article: the final, definitive, and citable version in the scholarly record.

The Published Journal Article includes:

The paper, revised and accepted following peer-review, in its final form, including the abstract, text, references, bibliography, and all accompanying tables, illustrations, data.
Any supplemental material.

Recognizing a published article as a finalized Published Journal Article establishes the expectation that it can be relied upon as accurate, complete, and citable.

Sometimes after an article has been published it may be necessary to make a change to the Published Journal Article. This will be done after careful consideration by the Editor who is also supported by OMF Publishing staff to ensure any necessary changes are made in accordance with guidance from the Committee on Publication Ethics (COPE).

Any necessary changes will be accompanied with a post-publication notice which will be permanently linked to the original article so that readers will be fully informed of any necessary changes. This can be in the form of a Correction notice, an Expression of Concern, a Retraction and in rare circumstances a Removal. The purpose of this mechanism of making changes which are permanent and transparent is to ensure the integrity of the scholarly record.

All correction, expressions of concern and retraction notices are free to access at the point of publication.

Duplicate Publication

Manuscripts containing original material are accepted for consideration if neither the article nor any part of its essential substance, tables, or figures has been or will be published or submitted elsewhere before appearing in the Journal (in part or in full, in other words or in the same words, in English or in another language), and will not be submitted elsewhere unless rejected by the Journal or withdrawn by the author. Simultaneous submissions of the same article to multiple journals are prohibited. If an author violates this requirement or engages in similar misconduct, the Journal’s Editorial Board may reject the manuscript or impose a moratorium on acceptance of new manuscripts from the author. If it deems the misconduct sufficiently serious, the Editorial Board can refer the matter for investigation to the author’s academic institution or hospital, to the appropriate state or local disciplinary body, and/or to the Ethics Committee of the Ukrainian Association for Maxillofacial and Oral Surgeons.

A letter of permission is required for any and all material that has been published previously or is “in press” by another journal. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, illustrations, and tables. These permissions must be supplied to the Journal upon submission of the article, along with ample acknowledgement of the original source of the materials in the legend and/or text.

To reiterate, any previously published material (including material published in foreign-language, open access, or e-journals) that is included in a submission to Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology needs to:

a) Clearly reference the original publication of the previously published material.

b) Be accompanied by a letter of permission from the copyright holder of the material. Any fee associated with permission to reuse previously published material is the responsibility of the author of the manuscript.

If an author submits an article to Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology that contains material to which he or she holds the copyright (figures, material from articles published on open-access or e-journals, and so on), he or she needs to clearly indicate that he or she holds the copyright and provide Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology with written permission to use the previously copyrighted material. Authors retain copyright of all material published in Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology.

All permission statements allowing Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology to publish previously published material must extend to all print and digital media (so that material can be both printed and placed on the journal’s website) and must not include any time limitations.

Plagiarism and Fabrication

Plagiarism is when an author passes off the work of someone else as his or her own. This can also include self-plagiarism, which happens when an author reuses portions of his or her previously published work without the proper references. Manuscripts containing plagiarized content will not be considered for publication in Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology.

If the journal learns of a case of plagiarism after publication, the Journal will conduct an investigation. If plagiarism is found, the author, the author’s institution and funding agencies, and the original publication will be notified. A statement noting the plagiarism, providing a reference to the plagiarized material, and linking to the original to the original paper may follow. Depending on the extent of the plagiarism, the paper may also be formally retracted.

Image Integrity

Illustrations should be labeled clearly. Illustrations should be arranged symmetrically, in either “portrait” or “landscape” orientation. Before-and-after photographs should be identical in terms of size, position, and lighting. All illustrations must be accompanied by figure legends, to be attached at the end of the manuscript.

No photographs, digital or otherwise, should be substantively modified.

Graphics altering programs can be used to assemble multi-panel images, clean up dust specs from scanning in originals, and cropping. However, these programs should not be used improperly to attempt to modify results. Tools such as “clone stamping” can often be detected due to a trail of “smudged” skin tone. There is zero tolerance for abusing digital photo editing software to change the appearance of clinical results.

Photographs must be taken with appropriate lighting and must be clearly in focus.

Bioethics and Clinical Trial Registration

Human and Animal Studies
Experimental studies on humans must include a statement that the study was approved by an Institutional Review Board (IRB) or ethics committee and that the subjects gave informed consent. Such approval should be described in the Methods section of the manuscript. In addition, for studies conducted with human subjects, the method by which informed consent was obtained from the participants (i.e., verbal or written) must be stated in the Methods section. Any systematic data gathering effort in patients or volunteers must be approved by an IRB or adhere to appropriate local/national regulations.

In situations where a formal IRB process is not available, the authors must indicate that the principles outlined in the Declaration of Helsinki have been followed. More information regarding the Declaration of Helsinki can be found at http://www.wma.net/en/30publications/10policies/b3/index.html

Experimental work on animals must conform to the guidelines laid out in the Guide for the Care and Use of Laboratory Animals, which is available from the National Academy of Science; a text-only version is available at http://www.nap.edu/readingroom/books/labrats/. Adherence to all relevant regulations and/or approval of the appropriate institutional Animal Care Committee or governmental licensure of the investigator and/or laboratory must be obtained. A statement concerning such approval must be included at the beginning of the Methods section.

Registering Clinical Trials
Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology requires that all articles reporting results of clinical trials be registered in a public trials registry that is in conformity with the International Committee of Medical Journal Editors (ICMJE). All clinical trials, regardless of when they were completed, and secondary analyses of original clinical trials should be registered before submission of a manuscript based on the trial. Phase I trials designed to study pharmacokinetics or major toxicity are exempt. Registering your trial is easy, free of charge, and helps promote science among a wide range of researchers.

Manuscripts reporting on clinical trials (as defined above) should indicate that the trials are registered and include the registry information on a separate page, immediately following the authors’ financial disclosure information. Required registry information includes trial registry name, registration identification number, and the URL for the registry.

Trials should be registered in one of the following trial registries:

http://www.clinicaltrials.gov/ (Clinical Trials)
http://actr.org.au (Australian Clinical Trials Registry)
http://isrctn.org (ISRCTN Register)
http://www.trialregister.nl/trialreg/index.asp (Netherlands Trial Register)
http://www.umin.ac.jp/ctr (UMIN Clinical Trials Registry)
http://www.who.int/ictrp/network/primary/en/index.html (An updated list of WHO-recognized Primary Registries which authors may use for registering their clinical trial)
http://www.ensaiosclinicos.gov.br (Brazilian Clinical Trials Registry [ReBec])

More information on registering clinical trials can be found in the following article: Rohrich RJ, Longaker MT. Registering clinical trials in Plastic and Reconstructive Surgery. Plast Reconstr Surg 2007;119(3):1097-9

Patient Consent for Identification in Photos, Videos, etc.

If patients in photographs or videos are identifiable, authors must obtain and provide to the Journal at the time of submission written consent from the patients. A standardized patient authorization form for the release of patient photographs and videos may be obtained from the Editorial Office or on-line at: https://dtjournal.org/. If an author chooses to use his or her own version for patient authorization, the form must include permission to use photographs for all types of media including but not limited to the following: print, visual, electronic, or broadcast media. Also, details in text that might identify patients, including but not limited to names, initials, and hospital numbers, must not be used unless essential for scientific purposes. If identification of patients is unavoidable, informed consents from the patients must be obtained.

Patient authorization and permission is needed to reproduce any photograph of a patient's face or identifiable body part. An identifiable tattoo on an otherwise unidentifiable body part effectively identifies the patient; patient permissions are required for these patients too. Photographs with bars placed over the eyes of patients are not allowed in place of patient authorization and permission.
If "deidentification" by sufficient cropping of a patient’s features is not possible, the authors need to obtain authorization and consent from the patient. If the patient cannot be located or refused to provide consent and authorization, the photograph must not be included in the manuscript submission.

In the event that the patient cannot provide consent due to death or legal incompetency (this includes photographs of corpses), permission from the power of attorney is needed as well as proof of power of attorney.

Embargo Policy

Any content submitted to the Journal must not be discussed with the media until the paper has published (online or in print, whichever occurs first). The Journal reserves the right to halt the consideration or publication of a paper if this policy is broken. If your paper is newsworthy, you may recommend a press release to the Editor or Editorial Office. You or your institution may also arrange for your own publicity; however you must strictly adhere to the Journal’s embargo policy and are advised to notify the Editorial Office if you or your institution chooses to conduct a press release.

Correction and Retraction Policy

Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology takes full responsibility to correct errors as they occur. Content that is published online or in an issue is considered the final published record and must be preserved; therefore all changes to articles must be made as a formal correction. Corrections will be published online and in the next available issue and will be bi-directionally linked to the original article.

Corrections will be reviewed and considered if they affect the publication record, the scientific integrity of the paper, or the reputation of the authors, or of the journal. Corrections that do not significantly affect the paper may not be approved (i.e. a spelling error).

Retractions will be considered if results are invalid or ethical guidelines have been violated (i.e. applicable cases of plagiarism or ghostwriting). All coauthors must sign a retraction detailing the error and how the conclusions were affected.

All decisions about corrections or retractions are made by the Editor. Author consultation may be required. In situations where coauthors disagree about a correction, the Editors will consult with independent peer-reviewers before applying the appropriate correction. The dissenting author(s) position will be noted on the correction.

DUTIES OF AUTHORS

Reporting Standards – the authors of manuscripts should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the manuscript. The manuscript should contain sufficient details and references to permit others to replicate the study. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Data Access and Retention – authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data, if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Originality and Plagiarism – the authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.

Multiple, Redundant or Concurrent Publication – an author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable.

Acknowledgement of Sources – proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.

Authorship of the Paper – authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made contributions should be listed as co-authors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are listed in the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Hazards and Human or Animal Subjects – if the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) has approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

Disclosure and Conflicts of Interest – all authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Fundamental Errors in Published Works – when an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

11. Publishing Schedule

This is a monthly publication which publishes issues at the last working day of every month.

12. Access

Our journal is a fully open access journal what means that all articles are free to read and to download.

13. Archiving

The publisher performed the journal`s electronic backup via V. I. Vernadskyi National Library of Ukraine, Kyiv, Ukraine.

14. Revenue Sources

Our journal and publisher apply publishing business model typical for the “pure gold” open access (i.e., fully open access) peer-reviewed journals which are supported by the payment of the article publishing charge and advertising. Publishing fees or waiver status does not influence editorial decision making.

15. Advertising

Advertising policy: The adverts (surgical devices, medications, etc.) in the format of A4 design page for (1) the home page (example of image and example of that image at the home page screen) and (2) for every issue (example issue) can be considered. There are examples of A4 size advertisement pages and examples of A4 size advertisement pages dedicated to medication leaflets. For advertising sales matters, contact our editorial office via email (editorial.office@dtjournal.org).

Advertisements can not be related in any way to editorial decision making and is keping separate from the published content.

16. Direct Marketing

All direct marketing activities that are conducted on behalf of the journal, is appropriate, well targeted, and unobtrusive.

17. Manuscript Stages after Acceptance or In Press Stages

"Article in Press" contains peer reviewed and accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated journal issue. Please be aware that "Articles in Press" do not have all bibliographic details available yet. There are four stages of "Articles in Press":

Accepted Manuscripts (also known as Pre-Proofs): These are manuscripts that have been selected for publication. They have not been typeset and the text may change before final publication. They can be cited using the year of online publication and the DOI, as follows: author(s), article title, journal (year), DOI. Please consult the journal's reference style for the exact appearance of these elements, abbreviation of journal names, and use of punctuation.
Uncorrected Proofs: These are articles that are not yet finalized and that will be corrected by the authors. Therefore the text could change before final publication. Uncorrected proofs may be temporarily unavailable for production reasons.
Corrected Proofs: These are articles containing the authors' corrections. The content of the article will usually remain unchanged, and possible further corrections are fairly minor. Typically the only difference with the finally published article is that specific issue and page numbers have not yet been assigned.
Withdrawn Article in Press: These are proofs of articles which have been peer reviewed and initially accepted, but have since been withdrawn before being published in this journal.

18. Guide For Authors

Here you can download the Guide for Authors (PDF).

19. Documents for Submission

Cover Letter (download template).
Copyright Transfer and Conflict of Interest Disclosure Form (download template).
Consent for Taking and Publishing Photographs (download template).
Manuscript (PDF/MS Word file).
Images from Figures and/or Videos (as a separate files). Video is encouraged with your article.

Sent 4 documents + separate images/video files to the Editorial Office email: editorial.office@dtjournal.org.

For article submission to the Section "Images in Oral and Maxillofacial Surgery" direct your manuscript to the Section Editor Dr. Mosquera: camilo.mosquera@dtjournal.org.

January 01, 2024 is a day of an official launch of the OMF Publishing Editorial System and the authors/reviewers will receive a possibity to use it with a lot of technological simplifications of submission and review process.

19. Articles for the Publication

original articles
review articles
case reports
case series
pictorial assays
images
surgical notes
reports of new equipment, instruments or technical innovations
article or book reviews
guest editorials

20. Requirements to the Manuscripts

Manuscripts and Abstracts

Manuscripts must be written in English.

One co-author is denominated as the corresponding author with all contact details:

Postal address (ZIP code of a country, City, Street, phone and fax number).
E-mail address.

The abstract should include full title of the article, full names and surnames of the co-authors, affiliation, scientific degree, specialty. Also the abstract should include short information about article content: purpose, material and methods, results, conclusions. Example how the Abstract should be looked like the authors can get from the published articles in current issue.

Figures and Tables

Photographs, ultrasonographic images, computed tomography (CT), and magnetic resonance imaging (MRI) should be submitted in original with resolution of at least 300 dpi and saved in JPEG or TIFF file format.

Fundings

The authors should indicate the sources of funding that were allocated for the preparation of the article, if such were the case.

Conflicts of Interest

At the end of the article the authors should specify about conflicts of interest (e.g., no conflict of interest).

Role of Co-authors in Writing

After specifying conflicts of interest the role of co-authors in writing of the article (concept and design of the study; material collection, material processing, statistical data processing, writing text, editing, etc.) should be designated.

Patient Consent

Written patient consent should be obtained to publish the clinical images of the patients.

Acknowledgments

The authors can acknowledge the persons or institutions which they helped or useful in writing an article.

The Journal is recommended to use that internet source for the articles preparing according to Vancouver References Style: http://libguides.murdoch.edu.au/Vancouver/journal

Examples How to Form a Refference List

List all references in numerical order in the text.

Example for the articles

Neto AMR, Monteiro JL, Borba PM, Melo AR, Barbosa LM, Vasconcelos BC. TMJ´s posterolateral dislocation with tympanic plate fracture − case report. J Diagn Treat Oral Maxillofac Pathol 2017;1(2):59−64. https://doi.org/10.23999/j.dtomp.2017.2.2

Example for the articles from the Journal Supplement

Hammerle CH, Chen ST, Wilson Jr TG. Consensus statements and recommended clinical procedures regarding the placement of implants in extraction sockets. Int J Oral Maxillofac Implants 2004;19(Suppl):26–8.

Hammerle CH, Chen ST, Wilson Jr TG. Consensus statements and recommended clinical procedures regarding the placement of implants in extraction sockets. Int J Oral Maxillofac Implants 2004;19:S26–8.

Example for the book chapters

Yuen HY, Ahuja AT. Benign clinical conditions in the adjacent neck. In: Sofferman RA, Ahuja AT, editors. Ultrasound of the thyroid and parathyroid glands. Springer, 2012:229−33. http://doi.org/10.1007/978-1-4614-0974-8

Example for the books

Baskin J, Duick D, Levine R. Thyroid ultrasound and ultrasound guided FNA. 2nd edition. New York: Springer; 2008.

Example for the PhD/ScD work (dissertation for candidate/doctor of science)

Borkowski MM. Infant sleep and feeding: a telephone survey of Hispanic Americans. PhD [dissertation]. Mount Pleasant (MI): Central Micihigan University; 2002.

Examples for references in Cyrillic

Please indicate the language of writing in square brackets [Ukrainian] or [Spanish].

Tymofieiev OO. Diseases of the salivary glands [Ukrainian]. 1st ed. Lviv: VNTL-Klasyka; 2007.

Examples for the internet links

Seave A. Elsevier CEO using unique data sets and analytic processes to maintain competitive edge. The Forbes. February 25, 2016. Available at: https://www.forbes.com/sites/avaseave/2016/02/25/elsevier-ceo-using-unique-data-sets-and-analytic-processes-to-maintain-competitive-edge/#1d9e4b3979c2/. Accessed February 25, 2016.

Adult improving access to psychological therapies programme. NHS England. Available from URL: https://www.england.nhs.uk/mental-health/adults/iapt/ (last accessed 3 March 2017).

Example for conference paper in print proceedings

Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming: EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.

Example for conference paper from the internet

Cloherty SL, Dokos S, Lovell NH. Qualitative support for the gradient model of cardiac pacemaker heterogeneity. In: Proceedings of the 2005 IEEE Engineering in Medicine and Biology 27 Annual Conference; 2005 Sep 1-4; Shanghai, China. New York: IEEE; 2005 [cited 2010 Sep 2]. p. 133-6. Available from: IEEE Xplore.

Example for A-V materials (DVD)

Acland RD, presenter. Acland's DVD atlas of human anatomy [DVD]. Baltimore (MD): Lippincott Williams & Wilkins; 2004.

Example for A-V materials (YouTube/Vimeo video)

NRK. Medieval helpdesk with English subtitles [video file]. 2007 Feb 26 [cited 2014 Jan 28]. Available from: https://www.youtube.com/watch?v=pQHX-SjgQvQ

Example for A-V materials (Video recording)

Hillel J, writer. Out of sight out of mind: indigenous people's health in Australia [videorecording]. Bendigo: Video Education Australasia; 2003.

Example for Readers/Study Guides

Lynch M. God's signature: DNA profiling, the new gold standard in forensic science. Endeavour. 2003;27(2):93-7. Reprinted In: Forensic Investigation (BIO373) unit reader for forensic DNA component. Murdoch (WA): Murdoch University; 2005.

Example for newspaper articles in print

Hatch, B. Smoke lingers for those who keep hospitality flowing. Australian Financial Review. 2006 Jul 13: 14.

Example for newspaper article from the internet

Devlin, H. Neuron breakthrough offers hope on Alzheimer’s and Parkinson’s. The Times [newspaper on the Internet]. 2010 Jan 28 [cited 2010 Jan 31]. Available from: http://www.timesonline.co.uk/tol/news/science/medicine/article7005401.ece.

Example for conversation citation

In a conversation with a colleague from the School of Population Health (Jameson LI 2002, oral communication, 7th August)...

Example for e-mail citation

Smith P. New research projects in gastroenterology [online]. E-mail to Matthew Hart (mh@hospital.wa.gov.au) 2000 Feb 5 [cited 2000 Mar 17].

Spelling and Grammar Check

The article should be 'spell checked' and 'grammar checked'. You can use American or British usage, but do not use mixture of them. Authors for whom English is not their native language should add an editing certificate (the international company that can provide editing is: www.enago.com).

Free Access for All Articles

The journal offers the free access to all articles. Editorial Board of the journal independently assigns for the articles the Digital Object Identifier (DOI) according to the international standards.

Questions?

E-mail: i.i.fesenko@dtjournal.org (Managing Editor)

Duties of Editors and Reviewers

DUTIES OF EDITORS

Publication Decision – the Editor in Chief/Managing Editor is responsible for deciding which of the articles submitted to the journal should be published. The editor may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editor may confer with other editors or reviewers in making this decision.

Fair Play – the Editor in Chief/Managing Editor and the reviewers evaluate manuscripts for their intellectual content without regard to the author’s race, ethnicity, gender, sexual orientation, religious beliefs, citizenship, or political ideology.

Confidentiality – the Editor in Chief/Managing Editor and the members of the editorial staff must ensure that all material submitted to the journal remains confidential while under review. The Editor-in-Chief and the editorial staff must not disclose any information about the submitted manuscript to anyone other than the corresponding author, reviewers, other editorial advisers, and the publisher.

Disclosure and Conflicts of interest – unpublished materials disclosed in a submitted manuscript must not be used in a Chief Editor/Editor’s own research without the express written consent of the author.

DUTIES OF REVIEWERS

Contribution to Editorial Decision – peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper.

Promptness – any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.

Confidentiality – any manuscripts received for review should be treated with strict confidentiality. They must not be shown to or discussed with others except when authorized by the Editor-in-Chief.

Standards of Objectivity – reviews should be conducted objectively. There shall be no personal criticism of the author. Reviewers should express their views clearly with supporting arguments.

Acknowledgement of Source – reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Disclosure and Conflicts of Interest – privileged information or ideas obtained through the peer review process must be kept confidential and must not be used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other connection with any of the authors, companies, or institutions connected to the manuscript.

HUMAN AND ANIMAL RIGHTS

If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans; Uniform Requirements for manuscripts submitted to Biomedical journals. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed.

Informed consent and patient details

Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an OMF Publishing publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.

Conflict of Interest

At the end of the text, under a subheading 'Conflict of Interest', all authors must disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.

Multiple, redundant or concurrent publication

An author should not in general publish manuscripts describing essentially the same research in more than one journal of primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical behaviour and is unacceptable.

In general, an author should not submit for consideration in another journal a paper that has been published previously, except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint.

Publication of some kinds of articles (e.g., clinical guidelines, translations) in more than one journal is sometimes justifiable, provided certain conditions are met. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication.

Please E-mail any questions you may have to our Editorial Office

E-mail: editorial.office@dtjournal.org